Current problems in the first-line treatment of metastatic breast cancer: focus on the role of docetaxel by Filippo Montemurro

Get full text

Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study by Thibaut Sanglier, Jinjoo Shim, Neil Lamarre, Claudia Peña-Murillo, Vincent Antao, Filippo Montemurro

Get full text

T-DM1 after Pertuzumab plus Trastuzumab: Treatment Sequence-Induced Selection Bias in HER2-Positive Metastatic Breast Cancer by Thibaut Sanglier, Alessandra Fabi, Carlos Flores, Evelyn M. Flahavan, Claudia Pena-Murillo, Anne-Marie Meyer, Filippo Montemurro

Get full text

“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”? by Stefan Kolling, Ferdinando Ventre, Elena Geuna, Melissa Milan, Alberto Pisacane, Carla Boccaccio, Carla Boccaccio, Anna Sapino, Anna Sapino, Filippo Montemurro

Get full text

Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives by Elisa Agostinetto, Filippo Montemurro, Fabio Puglisi, Carmen Criscitiello, Giampaolo Bianchini, Lucia Del Mastro, Martino Introna, Carlo Tondini, Armando Santoro, Alberto Zambelli

Get full text

Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review by Marianna Pellegrini, Fabio Dario Merlo, Elena Agnello, Taira Monge, Andrea Devecchi, Valentina Casalone, Filippo Montemurro, Ezio Ghigo, Anna Sapino, Simona Bo

Get full text

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report by Silvia Benvenuti, Melissa Milan, Elena Geuna, Alberto Pisacane, Rebecca Senetta, Gennaro Gambardella, Giulia M Stella, Filippo Montemurro, Anna Sapino, Carla Boccaccio, Paolo M Comoglio

Get full text

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients by Enrico Berrino, Umberto Miglio, Sara Erika Bellomo, Carla Debernardi, Alberto Bragoni, Annalisa Petrelli, Eliano Cascardi, Silvia Giordano, Filippo Montemurro, Caterina Marchiò, Tiziana Venesio, Anna Sapino

Get full text

Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study by Elena Geuna, Pasquale Lombardi, Rossella Martinello, Davide Garino, Alessandro Bonzano, Danilo Galizia, Annamaria Nuzzo, Paola Berchialla, Paolo Becco, Monica Mangioni, Lorena De Zarlo, Filippo Montemurro

Get full text

Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests by Mariarosaria Saponaro, Luigi Annunziata, Antonella Turla, Ilaria Viganò, Michele De Laurentiis, Mario Giuliano, Lucia Del Mastro, Filippo Montemurro, Fabio Puglisi, Carmine De Angelis, Giuseppe Buono, Francesco Schettini, Grazia Arpino

Get full text

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2... by Valentina Rossi, Paola Berchialla, Diana Giannarelli, Cecilia Nisticò, Gianluigi Ferretti, Simona Gasparro, Michelangelo Russillo, Giovanna Catania, Leonardo Vigna, Rossella Letizia Mancusi, Emilio Bria, Filippo Montemurro, Francesco Cognetti, Alessandra Fabi

Get full text

Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations by Andrea D’Arienzo, Annarita Verrazzo, Martina Pagliuca, Fabiana Napolitano, Sara Parola, Martina Viggiani, Roberta Caputo, Fabio Puglisi, Mario Giuliano, Lucia Del Mastro, Grazia Arpino, Michelino De Laurentiis, Filippo Montemurro

Get full text

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition by Federica Verginelli, Alberto Pisacane, Gennaro Gambardella, Antonio D’Ambrosio, Ermes Candiello, Marco Ferrio, Mara Panero, Laura Casorzo, Silvia Benvenuti, Eliano Cascardi, Rebecca Senetta, Elena Geuna, Andrea Ballabio, Filippo Montemurro, Anna Sapino, Paolo M. Comoglio, Carla Boccaccio

Get full text

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Developmen... by Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, Filippo Montemurro, Laura Biganzoli, Laura Cortesi, Alberto Zambelli, Carmen Criscitiello, Alessia Levaggi, Benedetta Conte, Massimo Calabrese, Alba Fiorentino, Caterina Marchiò, Corrado Tinterri, Veronica Andrea Fittipaldo, Giovanni Pappagallo, Stefania Gori

Get full text

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology by Federica Miglietta, Michela Cinquini, Maria Vittoria Dieci, Laura Cortesi, Carmen Criscitiello, Filippo Montemurro, Lucia Del Mastro, Alberto Zambelli, Laura Biganzoli, Alessia Levaggi, Chiara Delle Piane, Caterina Marchiò, Massimo Calabrese, Lucio Fortunato, Pierfrancesco Franco, Bruno Meduri, Veronica Andrea Fittipaldo, Stefania Gori

Get full text

Self‐evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study by Danilo Galizia, Andrea Milani, Elena Geuna, Rossella Martinello, Celeste Cagnazzo, Manuela Foresto, Virginia Longo, Paola Berchialla, Gianfranca Solinas, Adele Calori, Bruna Grasso, Chiara Volpone, Gisella Bertola, Gisella Parola, Giancarla Tealdi, Piero Luigi Giuliano, Anna Maria Ballari, Massimo Aglietta, Filippo Montemurro

Get full text

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas by Enrico Berrino, Laura Annaratone, Sara Erika Bellomo, Giulio Ferrero, Amedeo Gagliardi, Alberto Bragoni, Dora Grassini, Simonetta Guarrera, Caterina Parlato, Laura Casorzo, Mara Panero, Ivana Sarotto, Silvia Giordano, Matteo Cereda, Filippo Montemurro, Riccardo Ponzone, Nicola Crosetto, Alessio Naccarati, Anna Sapino, Caterina Marchiò

Get full text

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice by Giuseppe Buono, Grazia Arpino, Lucia Del Mastro, Lucia Del Mastro, Alessandra Fabi, Daniele Generali, Daniele Generali, Fabio Puglisi, Fabio Puglisi, Alberto Zambelli, Saverio Cinieri, Francesco Nuzzo, Vincenzo Di Lauro, Paolo Vigneri, Giampaolo Bianchini, Filippo Montemurro, Alessandra Gennari, Michelino De Laurentiis

Get full text

Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Mul... by Stefania Gori, Alessandro Inno, Valentina Rossi, Monica Turazza, Elena Fiorio, Alessandra Fabi, Giancarlo Bisagni, Jennifer Foglietta, Daniele Santini, Ida Pavese, Arianna Pellegrino, Alberto Zambelli, Patrizia Vici, Vita Leonardi, Sandro Barni, Silvana Saracchini, Giuseppe Bogina, Fabiana Marchetti, Simona Duranti, Gianluigi Lunardi, Filippo Montemurro

Get full text

Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients by Federica Miglietta, Letizia Pontolillo, Carmine De Angelis, Roberta Caputo, Monica Marino, Emilio Bria, Rossana Di Rienzo, Annarita Verrazzo, Carlo Buonerba, Giampaolo Tortora, Giuseppe Di Lorenzo, Lucia Del Mastro, Mario Giuliano, Filippo Montemurro, Fabio Puglisi, Valentina Guarneri, Michelino De Laurentiis, Luca Scafuri, Grazia Arpino

Get full text